Product profile A new generation of small diameter soft tissue level implant Straumann® Narrow Neck CrossFit® Standard Plus Implant
A
t the 27th Annual Academy of Osseointegration Meeting in Phoenix, Arizona, Straumann® introduced the Ø 3.3 mm Narrow Neck CrossFit® Standard Plus Soft Tissue Level Implant (NNC), now available in the U.S., Europe and Australia. Combining the high fatigue strength1 of Straumann’s Roxolid® material, the SLActive® surface that accelerates the osseointegration process,2 and the self-guiding CrossFit® connection, NNC is designed to provide excellent treatment outcomes in challenging treatment situations3 where space or bone is limited. Confidence when placing small diameter implants Small diameter implants are designed for placement in limited interdental spaces or narrow bone ridges and recommended for use in single-unit, multiple-unit, and fully edentulous situations3. The Roxolid® material has been the key to the development of NNC. Its high fatigue strength1 allowed for the development of a small diameter implant with an internal connection, while the SLActive® implant surface—one of the most investigated implant surfaces on the market with a multitude of studies providing scientific evidence to support its hydrophilic properties4— accelerates the osseointegration process2 and helps provide predictability in implant treatment. Wide range of treatment options The NNC offers comprehensive prosthetic options due to its narrow Ø 3.5 mm prosthetic platform with internal connection to include screw-retained and cement-retained restorations and your choice of implant-level or abutment-level impression workflow. The new implant has been integrated into Straumann’s Dental Implant System, which includes a full range of Soft Tissue and Bone Level options and requires only one surgical kit. Simplicity in daily use The self-guiding CrossFit® connection at soft-tissue level guides the abutment 50 0TWSHU[ practice
precisely into the correct position, offering improved prosthetic flexibility and optimized abutment insertion,5 while the New Transfer Piece with its snap-fit connection to implant and no need for use of a holding key simplifies handling during surgical placement. This Soft Tissue Level implant is designed to save time and increase efficiency in the dental practice. Innovative solutions Straumann is a pioneer of innovative solutions for implant dentistry, including the introduction of the SLA® surface in 1998, the revolutionary SLActive® surface in 2006, and the technologically advanced Roxolid® implant material in 2009. Now, 2012 heralds a new generation of small diameter tissue-level implant, thanks to the innovation and combination of Straumann’s innovative technologies, designs, and materials. The Roxolid® material The combination of the Roxolid® material and the SLActive® surface are designed to address the challenge of reduced surface area for osseointegration and the increased risk for implant fracture in cases where there is reduced availability of alveolar ridge width or interdental space. The first human study showing performance and tolerability of Roxolid® implants over 2 years showed that Roxolid® combines high implant stability and good osseointegration properties while still retaining adequate mechanical strength with a reduced implant diameter6 to give the clinician confidence when treating areas of limited space. This information was provided by Straumann USA.
About Straumann USA Straumann is a leading provider of solutions in implant dentistry and dental tissue regeneration. Its mission is to enable dental professionals to restore their patients’ oral function and esthetics through effective, reliable, and safe treatment methods. Straumann USA, LLC, located in Andover, Massachusetts, is the U.S. subsidiary of Straumann Holding, headquartered in Basel, Switzerland. As the largest dental implant company in the world, the Straumann Group of companies has an active presence in more than 50 countries.
References 1. Fatigue strength according to ISO 14801 internal tests, data on file (B679A/B567A). 2. Compared to SLA in an animal model. 3. Small diameter implants are not recommended for use in the molar region. 4. Straumann SLActive Scientific Evidence Brochure, 2011 (USLIT196). 5. Compared to Straumann Narrow Neck Implant. 6. Barter S, Stone P, Brägger U (2011). A pilot study to evaluate the success and survival rate of titanium-zirconium implants in partially edentulous patients: Results after 24 months follow-up. Clin Oral Implants Res. [Epub ahead of print]. Volume 5 Number 3